137 related articles for article (PubMed ID: 38602661)
1. The public health impacts of supervised injection sites in Canada: Moving beyond social acceptability and impacts on crime.
Côté-Lussier C; Rodrigues P
Can J Public Health; 2024 Jun; 115(3):468-471. PubMed ID: 38602661
[TBL] [Abstract][Full Text] [Related]
2. Supervised Injection Facilities as Harm Reduction: A Systematic Review.
Levengood TW; Yoon GH; Davoust MJ; Ogden SN; Marshall BDL; Cahill SR; Bazzi AR
Am J Prev Med; 2021 Nov; 61(5):738-749. PubMed ID: 34218964
[TBL] [Abstract][Full Text] [Related]
3. The value of harm reduction for injection drug use: A clinical and public health ethics analysis.
Vearrier L
Dis Mon; 2019 May; 65(5):119-141. PubMed ID: 30600096
[TBL] [Abstract][Full Text] [Related]
4. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
Wallace B; Pagan F; Pauly BB
Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
[TBL] [Abstract][Full Text] [Related]
5. Supervised Inhalation Sites: Preventing Overdose and Reducing Health Inequities among People Who Use Drugs.
Lu A; Kim C; Rosen JG; Thompson E; Tardif J; Welwean R; Park JN
Subst Use Misuse; 2024; 59(4):520-526. PubMed ID: 38044494
[TBL] [Abstract][Full Text] [Related]
6. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
Harris RE; Richardson J; Frasso R; Anderson ED
Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
[TBL] [Abstract][Full Text] [Related]
7. The ever-changing narrative: Supervised injection site policy making in Ontario, Canada.
Ziegler BR; Wray AJ; Luginaah I
Int J Drug Policy; 2019 Dec; 74():98-111. PubMed ID: 31586776
[TBL] [Abstract][Full Text] [Related]
8. Legal space for syringe exchange programs in hot spots of injection drug use-related crime.
Allen ST; Ruiz MS; Jones J; Turner MM
Harm Reduct J; 2016 Apr; 13():16. PubMed ID: 27112328
[TBL] [Abstract][Full Text] [Related]
9. Risk environments facing potential users of a supervised injection site in Ottawa, Canada.
Shaw A; Lazarus L; Pantalone T; LeBlanc S; Lin D; Stanley D; Chepesiuk C; Patel S; Tyndall M;
Harm Reduct J; 2015 Oct; 12():49. PubMed ID: 26493319
[TBL] [Abstract][Full Text] [Related]
10. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
[TBL] [Abstract][Full Text] [Related]
11. Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.
Kennedy MC; Hayashi K; Milloy MJ; Compton M; Kerr T
Addiction; 2022 Apr; 117(4):986-997. PubMed ID: 34854162
[TBL] [Abstract][Full Text] [Related]
12. Supervised injection services: what has been demonstrated? A systematic literature review.
Potier C; Laprévote V; Dubois-Arber F; Cottencin O; Rolland B
Drug Alcohol Depend; 2014 Dec; 145():48-68. PubMed ID: 25456324
[TBL] [Abstract][Full Text] [Related]
13. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
Davidson PJ; Lopez AM; Kral AH
Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
[TBL] [Abstract][Full Text] [Related]
14. My place, your place, or a safer place: the intention among Montréal injecting drug users to use supervised injecting facilities.
Green TC; Hankins CA; Palmer D; Boivin JF; Platt R
Can J Public Health; 2004; 95(2):110-4. PubMed ID: 15074900
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration.
Wolfson-Stofko B; Elliott L; Bennett AS; Curtis R; Gwadz M
Int J Drug Policy; 2018 Dec; 62():67-73. PubMed ID: 30359875
[TBL] [Abstract][Full Text] [Related]
16. Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.
Kennedy MC; Klassen DC; Dong H; Milloy MS; Hayashi K; Kerr TH
Am J Prev Med; 2019 Sep; 57(3):330-337. PubMed ID: 31377091
[TBL] [Abstract][Full Text] [Related]
17. Expanding supervised injection facilities across Canada: lessons from the Vancouver experience.
Young S; Fairbairn N
Can J Public Health; 2018 Apr; 109(2):227-230. PubMed ID: 29981039
[TBL] [Abstract][Full Text] [Related]
18. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
19. Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City.
Mitra S; Rachlis B; Scheim A; Bardwell G; Rourke SB; Kerr T
Harm Reduct J; 2017 Jul; 14(1):46. PubMed ID: 28709471
[TBL] [Abstract][Full Text] [Related]
20. Supervised injection facilities in Canada: past, present, and future.
Kerr T; Mitra S; Kennedy MC; McNeil R
Harm Reduct J; 2017 May; 14(1):28. PubMed ID: 28521829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
